Enabling you to exploit the value of enhanced bioavailability, increased solubility and improved stability.
It is estimated that over 80% of pharmaceutical pipeline API’s are poorly soluble in water. Leon’s ‘enabling nano now’ value proposition delivers novel, ready to use, validated, nano solutions that create value for partners and meets an unmet medical need for patients.
Our patented technology platforms offer access to the next generation of SMART nanoparticles™ and nano-formulated drugs, adding value at every stage of the chain from partners and payers to caregivers and patients.
The microjet reactor MJR® Technology platform is a classic bottom-up approach for particle synthesis and used for continuous precipitation of nano and microparticles. Enabling outstanding quality and reproducibility in particle sizes between 10 nm and 50 µm, it is scalable to every application, providing a proven alternative for most poorly soluble molecules, at a cost comparative to standard technologies.
At the forefront of innovation in the international pharmaceutical market, Leon is leading the way in supergenerics and high-barrier generics, revitalizing forgotten formulations and expediting APIs to deliver enhanced bioavailability, increased solubility and improved stability.
Our technology attributes include…
- Standardized, continuous processing and easy scale up
- Proprietary technology
- Tailored particles (nano and micro) 10nm-50 µm
- For oral, parenteral, transdermal and inhalation applications